San Francisco, CA, United States of America

Kevin R Shoemaker


Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 100(Granted Patents)


Location History:

  • San Francisco, CA (US) (1996 - 2005)
  • Emeryville, CA (US) (2008)

Company Filing History:


Years Active: 1996-2008

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kevin R Shoemaker: Innovator in Protease Regulation

Introduction

Kevin R Shoemaker is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of protease regulation, holding a total of 7 patents. His work focuses on developing innovative assays that enhance the understanding and application of protease inhibitors.

Latest Patents

One of his latest patents is the "Protease regulator screening assay." This invention involves a polypeptide that contains an anchor region, a protease recognition site, and a detectable signal region. The polypeptide can be produced recombinantly and directly attached to a solid support. It is particularly useful for screening protease regulators, especially protease inhibitors. This innovative approach has the potential to advance research in protease regulation significantly.

Career Highlights

Throughout his career, Kevin has worked with prominent companies such as Chiron Corporation and Arris Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his expertise in the field of protease regulation.

Collaborations

Kevin has collaborated with several notable individuals in his field, including Robert L Warne and David Y Chien. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kevin R Shoemaker is a distinguished inventor whose work in protease regulation has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to scientific progress and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…